<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00179387</url>
  </required_header>
  <id_info>
    <org_study_id>IRB #2003-412</org_study_id>
    <secondary_id>ACS Research Scholar's Grant</secondary_id>
    <nct_id>NCT00179387</nct_id>
  </id_info>
  <brief_title>Mind-Body Program for Cancer Patients</brief_title>
  <official_title>Evaluation of Mind-Body Groups on the Quality of Life of Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albert Einstein College of Medicine, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Cancer Society, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Albert Einstein College of Medicine, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out if Mind-Body groups can help improve the physical
      and emotional well-being of people facing cancer or its treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain, fatigue, anxiety, depression, nausea, sexual impairment, body image disturbance,
      relationship strains, existential distress and role losses are all potential &quot;side-effects&quot;
      of living with cancer and its treatment. Behavioral interventions have shown some success in
      mitigating distress and QOL impairment among cancer patients. The purpose of this
      randomized-controlled study is to compare the effects of Mind-body group interventions on the
      quality of life of patients with advanced cancer. Patients are randomized to one of two
      psychotherapy groups, which occur weekly for eight weeks. Quality of life assessments are
      conducted at baseline and two and four-month intervals.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2004</start_date>
  <completion_date type="Actual">February 25, 2016</completion_date>
  <primary_completion_date type="Actual">February 25, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Assessment of Cancer Therapy</measure>
    <time_frame>baseline to 2 months and 4 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">166</enrollment>
  <condition>Neoplasms</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Psycho-educational / Stress Management group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spiritual-Existential Support Group</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mind-Body Psychotherapy Group</intervention_name>
    <description>Psycho-educational group</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Stress Management Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mind-Body Psychotherapy Group</intervention_name>
    <description>Spiritual-Existential Group</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Spiritual Support Group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  On Active Treatment for:

        Breast Cancer Stage IV, Colorectal Cancer Stage IV, Lung Cancer Stages III &amp; IV, or All
        Other Cancers (ANY stage on treatment)

          -  Language is English or Spanish

        Exclusion Criteria:

          -  Patient is currently attending other support/psychotherapy group

          -  Significant Cognitive Impairment

          -  ECOG performance status = 3 or 4

          -  Current major untreated psychiatric disorder

          -  Unable to attend intervention in following 8 weeks due to medical or practical
             restrictions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alyson Moadel, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Albert Einstein College of Medicine</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.einstein.yu.edu/cancercenter/support</url>
    <description>Support programs for cancer patients &amp; their families in the Bronx</description>
  </link>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>January 23, 2017</last_update_submitted>
  <last_update_submitted_qc>January 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Albert Einstein College of Medicine, Inc.</investigator_affiliation>
    <investigator_full_name>Alyson Moadel</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Neoplasms</keyword>
  <keyword>Needs Assessment</keyword>
  <keyword>Adaptation Psychological</keyword>
  <keyword>Minority Groups</keyword>
  <keyword>Psychotherapy, Group</keyword>
  <keyword>Program Evaluation</keyword>
  <keyword>Spirituality</keyword>
  <keyword>Spiritual Therapies</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

